Blog and News Consultation opens on RoHS exemptions

Consultation opens on RoHS exemptions

The Oeko-Institut and Fraunhofer IZM have launched a stakeholder consultation on behalf of the European Commission on requests for three new RoHS exemptions and the renewal of three existing RoHS exemption.

The exemptions are shown in the table below:

Exemption number Description
Annex III, 39a (renewal) Cadmium selenide in downshifting cadmium-based semiconductor nanocrystal quantum dots for use in display lighting applications (< 0,2 μg Cd per mm2 of display screen area)
Annex III, 39a (renewal) Cadmium selenide in downshifting cadmium-based semiconductor nanocrystal quantum dots for use in display lighting applications (<0.1 μg per mm2 of display screen area)
New Cadmium (<1000 ppm) in luminescent material for on-chip application on LED semiconductor chips for use in lighting applications of at least CRI 80
Annex IV, 31a (renewal) Bis(ethylhexyl) phthalate, Dibutyl phthalate, Di-isobutyl phthalate and Benzyl butyl phthalate in spare parts recovered from and used for the repair or refurbishment of medical devices, including in vitro diagnostic medical devices, and their accessories, provided that the reuse takes place in auditable closed-loop business-to-business return systems and that each reuse of parts is notified to the customer
New Bis-(ethylhexyl) phthalate (DEHP) in ion selective electrodes for point of care analysis of ionic substances in human body fluids
New Bis-(ethylhexyl) phthalate (DEHP) in plastic strain relief devices used to prevent damage to cable connections to MRI imaging coils

Interested parties are invited to send their comments by e-mail, at the latest on 13 May 2019, to rohs.exemptions@oeko.de.

 

Please leave your comments:


Bevacizumab added to Proposition 65 List
Date: 13/03/2019

Bevacizumab added to Proposition 65 List

The California Office of Environmental Health Hazard Assessment has updated the list of chemicals known to the state to cause cancer or reproductive toxicity to include Bevacizumab. This chemical is sold under the trade name Avastin and is used as a cancer treatment.

Read more
Standard EU registration and reporting format established for producers of electrical and electronic equipment
Date: 25/02/2019

Standard EU registration and reporting format established for producers of electrical and electronic equipment

Commission Implementing Regulation (EU) 2019/290 establishes a harmonised data structure and format for the registration and reporting of producers of electrical and electronic equipment (EEE) for all EU Member States. This aims to reduce the administrative burden for producers operating in several Member States.

Read more